Regeneron(REGN) - 2024 Q2 - Quarterly Results

Exhibit 99.1 Press Release Regeneron Reports Second Quarter 2024 Financial and Operating Results • Second quarter 2024 revenues increased 12% to $3.55 billion versus second quarter 2023 • Second quarter 2024 Dupixent global net sales (recorded by Sanofi) increased 27% to $3.56 billion versus second quarter 2023 • Second quarter 2024 U.S. net sales for EYLEA HD and EYLEA increased 2% to $1.53 billion versus second quarter 2023, including $304 million from EYLEA HD • Second quarter 2024 Libtayo global net sal ...